Loading…
Accuray Incorporated is projected to rise to $0.2837 by 2027, a +5% move from its current price of $0.2698. ARAY is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean neutral.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.255 | $0.2699 | $0.2857 | +0.04% |
| Aug 6 | $0.2492 | $0.27 | $0.2926 | +0.08% |
| Aug 7 | $0.2449 | $0.2701 | $0.298 | +0.12% |
| Aug 8 | $0.2413 | $0.2702 | $0.3027 | +0.16% |
| Aug 9 | $0.2382 | $0.2703 | $0.3069 | +0.20% |
| Aug 10 | $0.2354 | $0.2705 | $0.3107 | +0.24% |
| Aug 11 | $0.2329 | $0.2706 | $0.3143 | +0.28% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.2329 | $0.2706 | $0.3143 | +0.28% |
| Week 2 | $0.2195 | $0.2713 | $0.3354 | +0.56% |
| Week 3 | $0.2098 | $0.2721 | $0.3528 | +0.85% |
| Week 4 | $0.2021 | $0.2728 | $0.3683 | +1.13% |
| Week 5 | $0.1956 | $0.2736 | $0.3827 | +1.41% |
| Week 6 | $0.19 | $0.2744 | $0.3962 | +1.70% |
| Week 7 | $0.185 | $0.2752 | $0.4092 | +1.99% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors. Its CyberKnife platform is a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. It also provides the TomoTherapy platform, including the Radixact System, which enables integrated treatment planning, delivery, and data management, along with iDMS data management system and the Accuray precision treatment planning system.
The company also offers post-contract customer support, installation, training, and other professional services. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.
Accuray Incorporated (ARAY) is a healthcare company focused on radiosurgery and radiation therapy systems. Its products include CyberKnife and TomoTherapy platforms with the Radixact System and related data management and planning tools. These systems are designed to treat tumors outside the brain, across a broad range of sites.
The company operates with a worldwide footprint and provides ongoing professional services to customers.
A major floor 39.5% below — a decisive break under it would weaken the trend.
The nearest floor, 14.8% below — buyers have tended to step in here.
The nearest ceiling, 29.7% above — a clean break opens room to run.
A major ceiling 77.9% above — clearing it would confirm fresh momentum.
Key ARAY support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ARAY market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.252 | Buy | $0.2596 | Buy |
| MA 10 | $0.248 | Buy | $0.2549 | Buy |
| MA 20 | $0.254 | Buy | $0.2606 | Buy |
| MA 50 | $0.3016 | Sell | $0.2988 | Sell |
| MA 100 | $0.3508 | Sell | $0.3965 | Sell |
| MA 200 | $0.6546 | Sell | $0.6374 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 50.46 | Neutral |
| Stoch RSI (14) | 73.59 | Neutral |
| CCI (20) | 79.60 | Neutral |
| Williams %R (14) | -33.33 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | 0.00 | Neutral |
| Bollinger %B (20,2) | 0.76 | Neutral |
| Stochastic %K (14) | 66.67 | Neutral |
| TRIX (15) | -0.92 | Sell |
| Awesome (5,34) | -0.02 | Sell |
| Ultimate (7,14,28) | 57.00 | Neutral |
| Momentum (10) | 0.01 | Buy |
| Aroon Osc (25) | -92.00 | Sell |
| Hull MA (9) | 0.27 | Buy |
| ADX (14) | 18.50 | Neutral |
| ATR (14) | 0.01 | Info |
The current technical picture is NEUTRAL with an RSI(14) of 60. The stock trades around the SMA50 of $0.302, well below the SMA200 of $0.6621, suggesting near-term momentum is balanced. The 30-day price range spans from $0.1961 to $0.4142, with a defined support at $0.23 and resistance at $0.35.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.23 | $0.2698 | $0.3812 | 0% | Neutral | |
| $0.2067 | $0.2837 | $0.4207 | +5% | Neutral | |
| $0.2289 | $0.3341 | $0.5288 | +24% | Bullish | |
| $0.1847 | $0.284 | $0.4722 | +5% | Neutral | |
| $0.15 | $0.2419 | $0.4189 | -10% | Neutral | |
| $0.1776 | $0.2995 | $0.5369 | +11% | Neutral | |
| $0.1913 | $0.3365 | $0.6222 | +25% | Bullish | |
| $0.2364 | $0.4331 | $0.8231 | +61% | Bullish | |
| $0.2459 | $0.4685 | $0.9132 | +74% | Bullish | |
| $0.2049 | $0.4058 | $0.8094 | +50% | Bullish | |
| $0.3004 | $0.6675 | $1.46 | +147% | Bullish | |
| $0.3928 | $0.8729 | $2.01 | +224% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.23 | $0.2698 | $0.3392 | +0.00% |
| September 2026 | $0.2202 | $0.2676 | $0.3394 | -0.81% |
| October 2026 | $0.2271 | $0.2799 | $0.3622 | +4.57% |
| November 2026 | $0.2358 | $0.294 | $0.3866 | +5.04% |
| December 2026 | $0.2268 | $0.2857 | $0.3812 | -2.80% |
Click any year to see its month-by-month ARAY forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The ARAY price prediction for 2026 points to an average of $0.2698 (low $0.23, high $0.3812) — a potential gain of 0% on today's $0.2698. Price action looks broadly range-bound.
In 2027, ARAY is projected to trade between $0.2067 and $0.4207, averaging $0.2837 — a potential gain of +5% from today's $0.2698. That is up +5% on the projected 2026 average. A consolidation phase looks the most probable path here.
Accuray Incorporated's 2028 outlook centres on $0.3341, within a $0.2289 to $0.5288 range. That is up +18% on the projected 2027 average. That marks a +24% change versus current levels. Momentum favours further upside here.
By 2029, ARAY could reach as high as $0.4722, with a base case around $0.284 and support toward $0.1847 — roughly +5% from $0.2698. A consolidation phase looks the most probable path here.
Expect ARAY to range from $0.15 to $0.4189 through 2030. The $0.2419 average target implies a -10% move from current prices. That is -15% versus the projected 2029 average. Price action looks broadly range-bound.
The ARAY price prediction for 2031 points to an average of $0.2995 (low $0.1776, high $0.5369) — a potential gain of +11% on today's $0.2698. A consolidation phase looks the most probable path here.
In 2032, ARAY is projected to trade between $0.1913 and $0.6222, averaging $0.3365 — a potential gain of +25% from today's $0.2698. That is up +12% on the projected 2031 average. Momentum favours further upside here.
Accuray Incorporated's 2033 outlook centres on $0.4331, within a $0.2364 to $0.8231 range. That is up +29% on the projected 2032 average. That marks a +61% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, ARAY could reach as high as $0.9132, with a base case around $0.4685 and support toward $0.2459 — roughly +74% from $0.2698. Momentum favours further upside here.
Expect ARAY to range from $0.2049 to $0.8094 through 2035. The $0.4058 average target implies a +50% move from current prices. That is -13% versus the projected 2034 average. Buyers look set to stay in control over this stretch.
The ARAY price prediction for 2040 points to an average of $0.6675 (low $0.3004, high $1.46) — a potential gain of +147% on today's $0.2698. Momentum favours further upside here.
In 2050, ARAY is projected to trade between $0.3928 and $2.01, averaging $0.8729 — a potential gain of +224% from today's $0.2698. That is up +31% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in ARAY today (≈ 3,706.449222 ARAY) could be worth
$3,235.37
+$2,235.37 (+224%) by 2050 · US Dollar
Based on the average projected ARAY price of $0.87 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ARAYwould be worth at today's price.
$1,000 invested in ARAY on Jul 31, 2025 (≈ 763.358812 ARAY) would be worth
$205.95
-$794.05 (-79.4%) today · 0.21× · US Dollar
Based on a ARAY entry price of $1.31 vs. today's $0.2698.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.24 | $1,124.17 | +12.4% |
| 1 month ago | $0.26 | $1,037.69 | +3.8% |
| 3 months ago | $0.47 | $574.04 | -42.6% |
| 6 months ago | $0.8 | $337.25 | -66.3% |
| 1 year ago | $1.31 | $205.95 | -79.4% |
| All time (5.0y) ago | $4.17 | $64.7 | -93.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ARAY forecast.
Our base-case forecast reaches $0.54 around 2040.
Implied market cap at $0.54: $64.49M
The multi-year forecast shows a mixed but increasingly positive path for average prices and returns. In 2030 the avg is $0.2582 with a max of $0.4472 and a ROI of -9.4%, signaling downside risk in that year. By 2040 the avg rises to $0.7263 with a max of $1.59 and a strong ROI of 154.8%, indicating a bullish longer-term trajectory.
In 2050 the avg is $0.9405 with a max of $2.16 and a substantial ROI of 230%, reflecting a notable upside potential by the end of the period.
Tap a question to reveal the answer.
The forecast for 2030 shows an avg of $0.2582 with a min of $0.16 and a max of $0.4472; the ROI is -9.4%.
The outlook includes years with positive returns, such as 2040 (avg $0.7263, ROI 154.8%) and 2050 (avg $0.9405, ROI 230%), but also a year with negative ROI (2030: -9.4%). This indicates potential upside but comes with risk and no guarantees.
The 2050 forecast max is $2.16, indicating a scenario where the price could exceed $1 within the horizon, though it is not a guarantee and depends on future conditions.
The current price is $0.285. The market shows an annualized volatility of 100% with a 30-day range from $0.1961 to $0.4142.
The 30-day range is $0.1961 to $0.4142, with current price around $0.285 and a nearby support at $0.23 and resistance at $0.35.
Accuray Incorporated Community Discussion
0Share your Accuray Incorporated price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.